136 related articles for article (PubMed ID: 11287412)
1. Regulation of the Src homology 2-containing inositol 5-phosphatase SHIP1 in HIP1/PDGFbeta R-transformed cells.
Saint-Dic D; Chang SC; Taylor GS; Provot MM; Ross TS
J Biol Chem; 2001 Jun; 276(24):21192-8. PubMed ID: 11287412
[TBL] [Abstract][Full Text] [Related]
2. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.
Ross TS; Gilliland DG
J Biol Chem; 1999 Aug; 274(32):22328-36. PubMed ID: 10428802
[TBL] [Abstract][Full Text] [Related]
3. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).
Ross TS; Bernard OA; Berger R; Gilliland DG
Blood; 1998 Jun; 91(12):4419-26. PubMed ID: 9616134
[TBL] [Abstract][Full Text] [Related]
4. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
Zhang J; Walk SF; Ravichandran KS; Garrison JC
J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
[TBL] [Abstract][Full Text] [Related]
6. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
[TBL] [Abstract][Full Text] [Related]
7. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL.
Sattler M; Verma S; Pride YB; Salgia R; Rohrschneider LR; Griffin JD
J Biol Chem; 2001 Jan; 276(4):2451-8. PubMed ID: 11031258
[TBL] [Abstract][Full Text] [Related]
8. pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets.
Giuriato S; Bodin S; Erneux C; Woscholski R; Plantavid M; Chap H; Payrastre B
Biochem J; 2000 May; 348 Pt 1(Pt 1):107-12. PubMed ID: 10794720
[TBL] [Abstract][Full Text] [Related]
9. Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB.
Malbec O; Schmitt C; Bruhns P; Krystal G; Fridman WH; Daëron M
J Biol Chem; 2001 Aug; 276(32):30381-91. PubMed ID: 11359765
[TBL] [Abstract][Full Text] [Related]
10. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins.
Wilbanks AM; Mahajan S; Frank DA; Druker BJ; Gilliland DG; Carroll M
Exp Hematol; 2000 May; 28(5):584-93. PubMed ID: 10812249
[TBL] [Abstract][Full Text] [Related]
11. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
[TBL] [Abstract][Full Text] [Related]
12. Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP.
Lamkin TD; Walk SF; Liu L; Damen JE; Krystal G; Ravichandran KS
J Biol Chem; 1997 Apr; 272(16):10396-401. PubMed ID: 9099679
[TBL] [Abstract][Full Text] [Related]
13. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.
Sternberg DW; Tomasson MH; Carroll M; Curley DP; Barker G; Caprio M; Wilbanks A; Kazlauskas A; Gilliland DG
Blood; 2001 Dec; 98(12):3390-7. PubMed ID: 11719379
[TBL] [Abstract][Full Text] [Related]
14. Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.
Ames HM; Wang AA; Coughran A; Evaul K; Huang S; Graves CW; Soyombo AA; Ross TS
Mol Cell Biol; 2013 Sep; 33(18):3580-93. PubMed ID: 23836884
[TBL] [Abstract][Full Text] [Related]
15. The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
Dunant NM; Wisniewski D; Strife A; Clarkson B; Resh MD
Cell Signal; 2000 May; 12(5):317-26. PubMed ID: 10822173
[TBL] [Abstract][Full Text] [Related]
16. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
Bruyns C; Pesesse X; Moreau C; Blero D; Erneux C
Biol Chem; 1999; 380(7-8):969-74. PubMed ID: 10494849
[TBL] [Abstract][Full Text] [Related]
17. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.
Damen JE; Liu L; Rosten P; Humphries RK; Jefferson AB; Majerus PW; Krystal G
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1689-93. PubMed ID: 8643691
[TBL] [Abstract][Full Text] [Related]
18. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.
Magnusson MK; Meade KE; Brown KE; Arthur DC; Krueger LA; Barrett AJ; Dunbar CE
Blood; 2001 Oct; 98(8):2518-25. PubMed ID: 11588050
[TBL] [Abstract][Full Text] [Related]
19. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
[TBL] [Abstract][Full Text] [Related]
20. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
